Search

Displaying results 6481 - 6490 of 10000 in total
  1. Drug

    Enokizumab

    go.drugbank.com/drugs/DB05555
    Investigational

    A humanized immunoglobulin G1k anti-interleukin-9 mAb.

  2. Drug

    Tanomastat

    go.drugbank.com/drugs/DB06276
    Experimental

  3. Drug

    Pramiconazole

    go.drugbank.com/drugs/DB06295
    Experimental

  4. Drug

    LX-2931

    go.drugbank.com/drugs/DB06297
    Investigational

  5. Drug

    Ilodecakin

    go.drugbank.com/drugs/DB06449
    Investigational

  6. Drug

    Odiparcil

    go.drugbank.com/drugs/DB06609
    Investigational

  7. Drug

    Sivifene

    go.drugbank.com/drugs/DB05686
    Investigational

  8. Drug

    Collagen-polyvinylpyrrolidone

    go.drugbank.com/drugs/DB16525
    Investigational

    It is characterized by antifibrotic, fibrolytic, and immunomodulatory properties[A227733]. … Collagen-polyvinylpyrrolidone is a copolymer generated from a mixture of type I collagen and low-molecular-weight PVP that has undergone γ irradiation[A227733].

  9. Drug

    Influenza B virus B/Austria/1359417/2021 live (attenuated) antigen

    go.drugbank.com/drugs/DB16902
    Approved

    Inactivated viruses cannot replicate and thus cannot cause disease from infection, even in immunocompromised individuals. … These vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which results in an immunological defense against future exposure to the virus, or "antigen

  10. Drug

    Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB16903
    ApprovedWithdrawn

    Inactivated viruses cannot replicate and thus cannot cause disease from infection, even in immunocompromised individuals. … These vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which results in an immunological defense against future exposure to the virus, or "antigen